New pancreatic cancer pill shows promise in early clinical trials
A daily pill called daraxonrasib, when taken with chemotherapy, has caused tumours to become undetectable on scans in one in 12 patients with advanced pancreatic cancer. While doctors caution that it is not a cure, the treatment represents a potential step forward in managing a disease that has historically been difficult to treat.
Source: BBC News UK
National
Read the full story